Group Leader, Measurement Science & Advanced Characterization (DDCS)

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us. Organization Overview : At Eli Lilly and Company, we unite caring with discovery to make life better for people around the world. Lilly has led global health care for more than 140 years. Our 50,000 employees work as one team to bring new medicines to the people who need them. We're looking for motivated, skilled scientists and engineers to help us keep that promise. Delivery, Devices, and Connected Solutions (DDCS) sits within Lilly's Product Research & Development organization. We're a team of scientists and engineers who discover, design, and develop patient-centered drug delivery solutions across many modalities — from injection devices to new routes of administration and nanomedicines. DDCS drives drug delivery innovation across early and late development for a growing portfolio of small molecules, biologics, and nucleic acid therapeutics. DDCS uses a matrix model, with strong functional teams supporting innovation and commercialization work. Our vision is to get medicines to more people, faster, guided by three pillars: Delivery Systems, Robust & Sustainable, and Patient Experience + Outcomes. Position Overview: The Measurement Science & Advanced Characterization team is a Center of Excellence within DDCS. The team generates the experimental data that validates computational models, informs device and container closure system design, supports regulatory submissions, and solves technical problems across the portfolio. This team is the experimental engine behind data-driven decisions in DDCS. The Group Leader, Measurement Science & Advanced Characterization sets the vision and builds the roadmap for measurement science capability across DDCS. This leader grows and runs a Center of Excellence that generates the experimental foundation for understanding how medicines, devices, and the body work together — from injection physiology and drug delivery mechanics to the performance of delivery devices as complete systems. This role expands the team's technical reach into new areas, including molecular device characterization and nanoparticle analytics, and champions tight collaboration between measurement science, modeling, and AI/data science. A core part of this role is transforming how the lab runs — using AI and automation to move the team into its next era of operation — while keeping full compliance with data integrity requirements (FDA 21 CFR Part 11, GxP, ALCOA+). Key Responsibilities : Vision, Strategy, & Team Leadership Set the vision and strategy for the DDCS Measurement Science team, and build and lead the roadmap to get there. Build, grow, and lead a high-performing team of diverse analytical scientists, imaging specialists, materials characterization experts, and container closure, device, and combination product test method scientists. Own the team's budget, headcount planning, and capital equipment strategy in line with DDCS portfolio priorities and business plan development. Build a culture of scientific excellence, curiosity, growth mindset, and collaborative problem-solving; coach and develop team members' careers. Set and maintain a high quality standards and ensure data integrity, safety, and other compliance requirements. Maintain rigorous data integrity (ALCOA+) and HSE compliance, and keep the lab inspection-ready at all times. Represent measurement science in DDCS business strategy, leadership forums and portfolio governance. Foundational Science & New Capability Development Establish new capabilities to characterize and understand the foundational physical and chemical processes behind injection physiology, drug delivery, and delivery devices as one continues system. Ensure the measurements are meaningful, accurate, and well grounded in patient safety and product efficacy. Expand team scope into molecular device characterization and nanoparticle analytics, identifying and building capability and/or establishing external collaboration and sourcing strategy to enable internal scientific development. Scan the field for emerging measurement techniques and analytical innovation relevant to new modalities, drug delivery science, container closure systems, devices, and combination products; run pilot studies to test and adopt promising new approaches. Guide investment decisions on new instrumentation and techniques based on portfolio need and scientific return. Cross-Functional Integration: DDCS capability (Modeling & AI/Data Science) and functional teams Champion close collaboration between measurement science, computational modeling (e.g. FEA, CFD, SciML), and AI/data science teams. Use data to enable and verify physics/data driven model performances. Direct experimental study design that feeds model development and validation — examples include material inputs, injection simulation data, CFD validation, and dimensional data for CAD verification. Enable model-informed drug/medicine development (MIDD) by pairing computational predictions with targeted experimental testing, building toward regulatory-grade models suitable for health authority submissions. Fully integrate measurement sciences into DDCS and PRD. Enable data driven decision making across DDCS – ranging from formulation and device design, container closure selection, novel drug delivery technologies, to combination product development and commercialization projects. Act as the escalation point for complex technical troubleshooting across drug delivery, device and container closure system, and combination product development programs. Direct advanced characterization work (imaging, surface characterization, CCIT, nanoparticle and materials characterization) to find failure mechanisms and degradation pathways. Lead root cause investigations into device failures, CCS integrity issues, and material problems, and provide rapid-response support when clinical or commercial timelines are at risk. Method Development & Regulatory Support Oversee development, validation, and lifecycle management of analytical methods for containers, closures, devices, and combination products, in line with ICH, 21 CFR Part 11, and GxP requirements. Deliver validation methods to enable the control strategy of drug/combination products. Accountable for tech transfer to commercial manufacturing sites to enable product and process validation and product launch. Build method libraries and knowledge repositories so the team's learning compounds over time. Direct authoring of technical sections for regulatory submissions related to test methods, characterization studies, and device testing. Lab Transformation: AI & Automation Lead the transforma